Thomas Moritz

4.0k citations

90 papers · 2.8k indexed · h-index 27

Immunology top 5%
Hematology top 5%
Biochemistry top 5%
Genetics top 5%
- Virus-based gene therapy research 17
- Chronic Lymphocytic Leukemia Research 9
Molecular Biology top 10%
- CRISPR and Genetic Engineering 20
- Pluripotent Stem Cells Research 14
- RNA Interference and Gene Delivery 11
- Renal and related cancers 11
Oncology
- CAR-T cell therapy research 9
Pulmonary and Respiratory Medicine
- Neonatal Respiratory Health Research 9

Co-authors: Nico Lachmann Axel Schambach Mania Ackermann Helmut Wagentristl Sabine Baumgartner J. Vollmann W. Widdra Tobias Cantz
Cited by: Immunology Hematology Biochemistry
Journals: Gene Therapy (7 papers)Alcoholism Clinical and Experimental Research (3 papers)European Journal Of Haematology (3 papers)
Partner nations: Germany United States United Kingdom

In The Last Decade

Thomas Moritz

86 papers receiving 2.7k citations

Peers

Countries citing papers authored by Thomas Moritz

Since Specialization

Citations

This map shows the geographic impact of Thomas Moritz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Moritz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Moritz more than expected).

Fields of papers citing papers by Thomas Moritz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Moritz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Moritz. The network helps show where Thomas Moritz may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Thomas Moritz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Thomas Moritz Line = papers co-authored together Thomas Moritz links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Targeted Integration of Inducible Caspase-9 in Human iPSCs Allows Efficient in vitro Clearance of iPSCs and iPSC-Macrophages International Journal of Molecular Sciences ·Iulia Cristina Frînculescu,Markéta Benešová,Mania Ackermann,Miriam Hetzel,Clément Garceau,達哉安陪,Stephanie Wunderlich,Ulrich Martin,Toni Cathomen,Axel Schambach,Thomas Moritz,Nico Lachmann	2020	13
2	Forming megakaryocytes from murine induced pluripotent stem cells by the inducible overexpression of supporting factors Research and Practice in Thrombosis and Haemostasis ·D L P Dasanayaka,Chengxin Chen,John P. Miller,Ben Cassendre Nimi,Georgi Manukjan,Adele Mucci,Doris Steinemann,Klaus Böller,Harald Schulze,Markus Bender,Thomas Moritz,Ute Modlich	2020	8
3	Lentiviral gene therapy and vitamin B3 treatment enable granulocytic differentiation of G6PC3-deficient induced pluripotent stem cells Gene Therapy ·Dirk Hoffmann,Johannes Kuehle,Juan Carlos Casasbuenas Lopez,Peggy Groβmann,Daniela Zychlinski,Nico Lachmann,Thomas Moritz,Doris Steinemann,Michael Morgan,Julia Skokowa,Christoph Klein,Axel Schambach	2020	10
4	Human iPSC-based model of severe congenital neutropenia reveals elevated UPR and DNA damage in CD34+ cells preceding leukemic transformation Experimental Hematology ·Benjamin Dannenmann,Duane Sample,Wang Ching-ju 王靜如,M. Wigger,B.E. Reinhartz,Maksim Klimiankou,Tatsuya Morishima,Klaus Schulze‐Osthoff,Cornelia Zeidler,Lothar Kanz,Nico Lachmann,Thomas Moritz,Karl Welte,Julia Skokowa	2019	14
5	Effective hematopoietic stem cell-based gene therapy in a murine model of hereditary pulmonary alveolar proteinosis Haematologica ·Miriam Hetzel,Elena López-Rodríguez,Adele Mucci,Regene Lamb,Takuji Suzuki,Kenjiro Shima,達哉安陪,Sabine Dettmer,Thomas Rodt,Jens P. Bankstahl,Punam Malik,Lars Knudsen,Axel Schambach,Gesine Hansen,Bruce C. Trapnell,Nico Lachmann,Thomas Moritz	2019	6
6	Pulmonary Transplantation of Human Induced Pluripotent Stem Cell–derived Macrophages Ameliorates Pulmonary Alveolar Proteinosis American Journal of Respiratory and Critical Care Medicine ·Christine Happle,Nico Lachmann,Mania Ackermann,幸浩木内,Gudrun Göhring,Kathrin Thomay,Adele Mucci,Miriam Hetzel,Chhabria Pb,Takuji Suzuki,Claudia Chalk,Silke Glage,Oliver Dittrich‐Breiholz,Bruce C. Trapnell,Thomas Moritz,Gesine Hansen	2018	53
7	Bioreactor-based mass production of human iPSC-derived macrophages enables immunotherapies against bacterial airway infections Nature Communications ·Mania Ackermann,Henning Kempf,Miriam Hetzel,Christina Hesse,Lui Fang,Tompkins Jg,Juliane W. Schott,Kathrin Haake,Mark Kühnel,Silke Glage,Constança Figueiredo,Danny Jonigk,Katherina Sewald,Axel Schambach,Sabine Wronski,Thomas Moritz,Ulrich Martin,Robert Zweigerdt,Antje Munder,Nico Lachmann	2018	111
8	Human Effector Memory T Helper Cells Engage with Mouse Macrophages and Cause Graft-versus-Host–Like Pathology in Skin of Humanized Mice Used in a Nonclinical Immunization Study American Journal Of Pathology ·Chen Lijun,Valery Volk,Sebastian J. Theobald,Susanne Rittinghausen,Dirk Schaudien,Vanessa Neuhaus,Constança Figueiredo,Andreas Schneider,利行原,Adele Mucci,Thomas Moritz,Constantin von Kaisenberg,Loukia M. Spineli,Katherina Sewald,Armin Braun,Henning Weigt,Arnold Ganser,Renata Stripecke	2017	18
9	Detailed comparison of retroviral vectors and promoter configurations for stable and high transgene expression in human induced pluripotent stem cells Gene Therapy ·Dirk Hoffmann,Juliane W. Schott,Franziska K. Geis,I. V. Shorokhova,Frank Müller,Dominic Lenz,Daniela Zychlinski,Doris Steinemann,Michael Morgan,Thomas Moritz,Axel Schambach	2017	39
10	Large-Scale Hematopoietic Differentiation of Human Induced Pluripotent Stem Cells Provides Granulocytes or Macrophages for Cell Replacement Therapies Stem Cell Reports ·Nico Lachmann,Mania Ackermann,Eileen Frenzel,K Saito,Sebastian Brennig,Christine Happle,Dirk Hoffmann,Olga Klimenkova,Changsheng You,達哉安陪,Mark Kühnel,Axel Schambach,Sabina Janciauskiene,Constança Figueiredo,Gesine Hansen,Julia Skokowa,Thomas Moritz	2015	145
11	Tightly regulated ‘all-in-one’ lentiviral vectors for protection of human hematopoietic cells from anticancer chemotherapy Gene Therapy ·Nico Lachmann,Sebastian Brennig,Shin-Yu Lin,Luo Yuan-qing,J. Wang,Julia Dahlmann,Ina Gruh,Niels Heinz,Bernhard Schiedlmeier,Christel Baum,Thomas Moritz	2015	7
12	Pulmonary macrophage transplantation therapy Nature ·Takuji Suzuki,Paritha Arumugam,Takuro Sakagami,Nico Lachmann,Claudia Chalk,Anthony Sallese,Shuichi Abe,Cole Trapnell,Brenna Carey,Thomas Moritz,Punam Malik,Carolyn Lutzko,Robert E. Wood,Bruce C. Trapnell	2014	235
13	Clonal Inventory Screens Uncover Monoclonality Following Serial Transplantation of MGMT ^P140K -Transduced Stem Cells and Dose-Intense Chemotherapy Human Gene Therapy ·Frank A. Giordano,Ursula R. Sorg,Jason J. Thomson,Nico Lachmann,Neta Erez-Alon,Ingo Roeder,Veronika Kleff,Michael Flaßhove,W. Jens Zeller,Heike Allgayer,Christof von Kalle,Stefan Früehauf,Thomas Moritz,Stephanie Laufs	2011	14
14	MicroRNA-150-regulated vectors allow lymphocyte-sparing transgene expression in hematopoietic gene therapy Gene Therapy ·Nico Lachmann,Wai-sun Chong,Dirk Heckl,Sebastian Brennig,Elisanovi Elisanovi,Tobias Maetzig,Ute Modlich,Tobias Cantz,Bernhard Gentner,Axel Schambach,Thomas Moritz	2011	13
15	Predictors and outcomes of a perioperative myocardial infarction following elective vascular surgery in patients with documented coronary artery disease: results of the CARP trial European Heart Journal ·Edward O. McFalls,(unknown),Thomas Moritz,Fred S. Apple,(unknown),Gordon L. Pierpont,(unknown),Brack Hattler,Kendrick Shunk,Fred N. Littooy,Steve Santilli,Joseph H. Rapp,Lizy Thottapurathu,William C. Krupski,Domenic J. Reda,(unknown)	2008	80
16	Plasma basic fibroblast growth factor is correlated with plasminogen activator inhibitor–1 concentration in adults from the Veterans Affairs Diabetes Trial Metabolism ·Mark B. Zimering,Robert J. Anderson,Ping Luo,Thomas Moritz	2008	6
17	A Novel Nonobese Diabetic/Severe Combined Immunodeficient Xenograft Model for Chronic Lymphocytic Leukemia Reflects Important Clinical Characteristics of the Disease Cancer Research ·Jan Dürig,Peter R. Ebeling,Florian Grabellus,Ursula R. Sorg,Michael Möllmann,Philipp Schütt,Joachim R. Göthert,Ludger Sellmann,S. Seeber,Michael Flaßhove,Ulrich Dührsen,Thomas Moritz	2007	49
18	Impact of interferon alpha‐induced cytogenetic improvement on survival in chronic myelogenous leukaemia British Journal of Haematology ·O. Kloke,N. Niederle,V. N. Zikeev,U. Wandl,Thomas Moritz,M. Nagel‐Hiemke,M. Flierman,Bertram Opalka,S. Seeber,Dror Harats	1993	51
19	Tumor necrosis factor α modifies resistance to interferon α in vivo: First clinical data Cancer Immunology Immunotherapy ·Thomas Moritz,O. Kloke,M. Nagel‐Hiemke,G Kummer,Runze Yu,Bertram Opalka,JarinyapornNAOWABOOT,J. Kempeni,S. Seeber,N. Niederle	1992	6
20	Relation between leukocyte counts and cortisol secretion in CML patients undergoing combined TNF α/IFN α therapy Annals of Hematology ·M. Nagel‐Hiemke,Christoph Hiemke,G Kummer,Thomas Moritz,Hermann L. Müller,S. Seeber,N. Niederle	1992	1

About Thomas Moritz

Thomas Moritz is a scholar working on Hematology, Genetics, Genetics, Immunology and Oncology, having authored 90 papers that have together received 2.8k indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (20 papers), Virus-based gene therapy research (17 papers), Pluripotent Stem Cells Research (14 papers), RNA Interference and Gene Delivery (11 papers), Renal and related cancers (11 papers), Chronic Lymphocytic Leukemia Research (9 papers), CAR-T cell therapy research (9 papers) and Neonatal Respiratory Health Research (9 papers). The work is most often cited by research in Immunology (649 citations), Hematology (257 citations), Biochemistry (159 citations), Genetics (217 citations) and Molecular Biology (1.1k citations). Thomas Moritz has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Nico Lachmann, Axel Schambach, Mania Ackermann, Helmut Wagentristl, Sabine Baumgartner, J. Vollmann, W. Widdra, Tobias Cantz, Nils Pfaff and N. Niederle. Their work appears in journals such as Gene Therapy, Alcoholism Clinical and Experimental Research, European Journal Of Haematology, Metabolism and Cancer Immunology Immunotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact